as a medical technology company, we improve lives by providing innovative spine surgery solutions through our relentless pursuit of superior outcomes. we are dedicated to the design, development, launch and the delivery of spinal fusion products. we seek to accomplish this by working with spine surgeons to design and develop products and systems that address the entire spinal fusion procedure in the most effective and efficient way possible. our product designs and platforms provide innovation through a focus on simplifying procedures for the surgeon with the ultimate objective of superior outcomes. alphatec spine is seeking growth through innovation and continually developing technologies that will have a greater positive impact on patient care and outcomes. please visit our website for more information: www.alphatecspine.com
Company profile
Ticker
ATEC
Exchange
Website
CEO
Terry Rich
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
Subsidiaries
Alphatec Spine, Inc. • EOS imaging S.A.S. ...
IRS number
202463898
ATEC stock data
Latest filings (excl ownership)
8-K
Regulation FD Disclosure
19 Mar 24
S-8
Registration of securities for employees
28 Feb 24
10-K
2023 FY
Annual report
27 Feb 24
8-K
ATEC Reports Fourth Quarter and Full-Year 2023 Financial Results
27 Feb 24
8-K
ATEC Announces Record Preliminary Revenue Results for 2023
8 Jan 24
8-K
Departure of Directors or Certain Officers
3 Jan 24
10-Q
2023 Q3
Quarterly report
6 Nov 23
8-K
ATEC Reports Third Quarter 2023 Financial Results and Raises Full Year 2023 Adjusted EBITDA Guidance
6 Nov 23
8-K
ATEC Announces Pricing of Public Offering of Common Stock
26 Oct 23
424B5
Prospectus supplement for primary offering
26 Oct 23
Transcripts
ATEC
Earnings call transcript
2023 Q4
27 Feb 24
ATEC
Earnings call transcript
2023 Q3
6 Nov 23
ATEC
Earnings call transcript
2023 Q2
3 Aug 23
ATEC
Earnings call transcript
2023 Q1
4 May 23
ATEC
Earnings call transcript
2023 Q1
4 May 23
ATEC
Earnings call transcript
2022 Q4
28 Feb 23
ATEC
Earnings call transcript
2022 Q3
6 Nov 22
ATEC
Earnings call transcript
2022 Q2
6 Aug 22
ATEC
Earnings call transcript
2022 Q1
8 May 22
ATEC
Earnings call transcript
2021 Q4
2 Mar 22
Latest ownership filings
SC 13D/A
L-5 Healthcare Partners, LLC
22 Mar 24
4
Evan Bakst
18 Mar 24
4
Patrick Miles
8 Mar 24
4
Quentin S. Blackford
8 Mar 24
4
Tyson Eliot Marshall
8 Mar 24
4/A
Paul Segal
6 Mar 24
144
Notice of proposed sale of securities
6 Mar 24
4
Tyson Eliot Marshall
4 Mar 24
4
John Todd Koning
4 Mar 24
144
Notice of proposed sale of securities
1 Mar 24
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 122.53 mm | 122.53 mm | 122.53 mm | 122.53 mm | 122.53 mm | 122.53 mm |
Cash burn (monthly) | (no burn) | (no burn) | 14.26 mm | 14.42 mm | 5.76 mm | 5.16 mm |
Cash used (since last report) | n/a | n/a | 84.78 mm | 85.74 mm | 34.26 mm | 30.67 mm |
Cash remaining | n/a | n/a | 37.75 mm | 36.79 mm | 88.26 mm | 91.86 mm |
Runway (months of cash) | n/a | n/a | 2.6 | 2.6 | 15.3 | 17.8 |
Institutional ownership, Q3 2023
70.3% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 195 |
Opened positions | 31 |
Closed positions | 46 |
Increased positions | 74 |
Reduced positions | 51 |
13F shares | Current |
---|---|
Total value | 882.24 bn |
Total shares | 96.97 mm |
Total puts | 54.70 k |
Total calls | 352.30 k |
Total put/call ratio | 0.2 |
Largest owners | Shares | Value |
---|---|---|
Squadron Capital | 11.54 mm | $144.53 mm |
L-5 Healthcare Partners | 11.08 mm | $172.93 mm |
BLK Blackrock | 5.71 mm | $74.07 bn |
Millennium Management | 5.71 mm | $74.06 bn |
Vanguard | 4.62 mm | $59.86 bn |
Gen IV Investment Opportunities | 3.99 mm | $23.48 mm |
First Light Asset Management | 3.03 mm | $39.35 bn |
American Century Companies | 2.66 mm | $34.44 bn |
Driehaus Capital Management | 2.53 mm | $32.77 bn |
Fred Alger Management | 2.34 mm | $30.31 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
14 Mar 24 | Bakst Evan | Common Stock | Buy | Acquire P | Yes | No | 13.53 | 15,000 | 202.95 k | 15,000 |
7 Mar 24 | Blackford Quentin S. | Common Stock | Buy | Acquire P | No | No | 12.83 | 20,000 | 256.60 k | 572,605 |
6 Mar 24 | Tyson Eliot Marshall | Common Stock | Sell | Dispose S | No | Yes | 13.16 | 9,225 | 121.40 k | 295,870 |
1 Mar 24 | Tyson Eliot Marshall | Common Stock | Sell | Dispose S | No | Yes | 13.3 | 11,825 | 157.27 k | 305,095 |
1 Mar 24 | John Todd Koning | Common Stock | Sell | Dispose S | No | Yes | 13.3 | 121,601 | 1.62 mm | 430,856 |
News
Needham Maintains Buy on Alphatec Holdings, Raises Price Target to $23
28 Mar 24
Canaccord Genuity Reiterates Buy on Alphatec Holdings, Maintains $25 Price Target
20 Mar 24
A Closer Look at 4 Analyst Recommendations For Alphatec Holdings
13 Mar 24
Critical Insights From Alphatec Holdings Analyst Ratings: What You Need To Know
13 Mar 24
Needham Reiterates Buy on Alphatec Holdings, Maintains $19 Price Target
13 Mar 24